Go Pro

Alnylam Pharmaceuticals (ALNY) Institutional Ownership

Alnylam Pharmaceuticals logo
$236.22 +6.92 (+3.02%)
As of 08/21/2026 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

Current
Institutional Ownership
Percentage
92.97%
Number of
Institutional Buyers
(last 12 months)
566
Total
Institutional Inflows
(last 12 months)
$7.62B
Number of
Institutional Sellers
(last 12 months)
306
Total
Institutional Outflows
(last 12 months)
$88.86B
Get ALNY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Alnylam Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ALNY Institutional Buying and Selling by Quarter

Alnylam Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/23/2026 Wedmont Private Capital1,413$422K0.0%+15.6%0.001%
8/23/2026 HB Wealth Management LLC1,824$549K0.0%-8.6%0.001%
8/23/2026 Saudi Central Bank9,284$2.80M0.0%+90.4%0.007%
8/22/2026 AlphaGrep UK Ltd1,623$489K0.1%N/A0.001%
8/22/2026 Raiffeisen Bank International AG13,510$3.97M0.0%+29.7%0.010%
8/22/2026 denkapparat Operations GmbH2,594$781K0.3%+151.4%0.002%
8/22/2026 TD Waterhouse Canada Inc.1,825$551K0.0%-7.4%0.001%
8/22/2026 Concurrent Investment Advisors LLC7,521$2.26M0.0%+695.9%0.006%
8/22/2026 NEOS Investment Management LLC78,274$23.56M0.1%+13.6%0.058%
8/21/2026 Orion Capital Management LLC2,155$649K0.2%-24.5%0.002%
8/21/2026 Nykredit A S51,208$15.42M0.0%N/A0.038%
8/21/2026 B. Metzler seel. Sohn & Co. AG10,591$3.19M0.0%+25.0%0.008%
8/20/2026 Proficio Capital Partners LLC919$277K0.0%N/A0.001%
8/20/2026 Quantitative Investment Management LLC7,981$2.40M0.3%+106.9%0.006%
8/20/2026 Two Sigma Securities LLC5,585$1.68M0.1%N/A0.004%
8/20/2026 Benjamin Edwards Inc.1,168$352K0.0%+7.6%0.001%
8/20/2026 GTS Securities LLC1,452$437K0.0%+38.0%0.001%
8/20/2026 Northwestern Mutual Wealth Management Co.1,151$346K0.0%+25.7%0.001%
8/19/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC727,848$219.10M0.0%+7.4%0.544%
8/19/2026 Royal London Asset Management Ltd.213,589$64.30M0.1%-0.7%0.160%
8/19/2026 Van ECK Associates Corp58,666$17.66M0.0%+8.4%0.044%
8/19/2026 Nissay Asset Management Corp Japan39,482$11.89M0.1%+7.0%0.030%
8/19/2026 Wellington Management Group LLP2,110,407$635.30M0.1%+9.0%1.577%
8/18/2026 Beacon Pointe Advisors LLC1,144$344K0.0%N/A0.001%
8/18/2026 Livforsakringsbolaget Skandia Omsesidigt1,000$301K0.0%N/A0.001%
8/18/2026 Rakuten Investment Management Inc.17,961$5.27M0.0%N/A0.013%
8/18/2026 Orion Capital Management LLC2,155$649K0.2%N/A0.002%
8/18/2026 North Star Asset Management Inc.1,105$333K0.0%N/A0.001%
8/18/2026 Empowered Funds LLC4,355$1.31M0.0%N/A0.003%
8/18/2026 United Capital Financial Advisors LLC4,155$1.25M0.0%N/A0.003%
8/18/2026 Coastal Bridge Advisors LLC941$283K0.0%N/A0.001%
8/18/2026Jefferies Financial Group Inc.22,095$6.65M0.0%N/A0.017%
8/18/2026 Public Employees Retirement System of Ohio37,998$11.44M0.0%N/A0.028%
8/18/2026 MASTERINVEST Kapitalanlage GmbH1,251$377K0.0%N/A0.001%
8/17/2026 Capstone Investment Advisors LLC1,899$572K0.0%N/A0.001%
8/17/2026 Proficio Capital Partners LLC919$277K0.0%N/A0.001%
8/17/2026 Transamerica Financial Advisors LLC8,288$2.50M0.2%N/A0.006%
8/17/2026 Corient Private Wealth LP23,797$7.16M0.0%N/A0.018%
8/15/2026 Strategic Global Advisors LLC4,823$1.45M0.2%N/A0.004%
8/15/2026 Caisse de depot et placement du Quebec85,748$25.81M0.0%N/A0.064%
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
8/15/2026 Man Group plc170,907$51.45M0.1%N/A0.128%
8/15/2026 Jupiter Topco LLC135,545$40.81M0.0%N/A0.101%
8/14/2026 Canada Pension Plan Investment Board334,246$100.62M0.1%N/A0.250%
8/14/2026 Parkman Healthcare Partners LLC50,672$15.25M1.6%N/A0.038%
8/14/2026 Legal & General Group Plc924,561$278.32M0.1%N/A0.691%
8/14/2026 Brandywine Managers LLC2,318$698K0.3%N/A0.002%
8/14/2026 L2 Asset Management LLC768$231K0.0%N/A0.001%
8/13/2026 Cibc World Market Inc.7,221$2.17M0.0%N/A0.005%
8/13/2026 OMERS ADMINISTRATION Corp4,517$1.36M0.0%N/A0.003%
8/13/2026 Osmosis Investment Management UK Ltd3,638$1.10M0.1%N/A0.003%
8/13/2026 Sanctuary Advisors LLC3,139$945K0.0%N/A0.002%
8/13/2026 Polymer Capital Management HK LTD64,957$19.55M1.0%N/A0.049%
8/13/2026 Connor Clark & Lunn Investment Management Ltd.666$200K0.0%N/A0.000%
8/13/2026 Meiji Yasuda Asset Management Co Ltd.1,085$327K0.0%N/A0.001%
8/13/2026 Bank of Nova Scotia8,130$2.45M0.0%N/A0.006%
8/12/2026 Elevation Point Wealth Partners LLC1,316$396K0.0%N/A0.001%
8/12/2026 Daiichi Life Insurance Co. Ltd.5,873$1.77M0.0%N/A0.004%
8/12/2026 Commerce Bank9,461$2.85M0.0%N/A0.007%
8/12/2026 Northwestern Mutual Wealth Management Co.1,151$346K0.0%N/A0.001%
8/12/2026 Evolve Private Wealth LLC882$266K0.0%N/A0.001%
8/12/2026 Westpac Banking Corp2,632$792K0.0%N/A0.002%
8/12/2026 Sumitomo Life Insurance Co.3,111$937K0.0%N/A0.002%
8/12/2026 Korea Investment CORP247,660$74.55M0.1%N/A0.185%
8/12/2026 EP Wealth Advisors LLC791$238K0.0%N/A0.001%
8/12/2026 Ieq Capital LLC15,410$4.64M0.0%N/A0.012%
8/12/2026 Callan Family Office LLC3,078$927K0.0%N/A0.002%
8/11/2026 Keating Financial Advisory Services Inc.139$42K0.0%N/A0.000%
8/11/2026 Allworth Financial LP1,099$331K0.0%N/A0.001%
8/11/2026 B. Metzler seel. Sohn & Co. AG10,591$3.19M0.0%N/A0.008%
8/11/2026 Silvant Capital Management LLC18,126$5.46M0.2%N/A0.014%
8/11/2026 Vise Technologies Inc.1,242$374K0.0%N/A0.001%
8/11/2026 E Fund Management Co. Ltd.6,073$1.83M0.0%N/A0.005%
8/11/2026 Asahi Life Asset Management CO. LTD.1,388$418K0.2%N/A0.001%
8/10/2026 Shepherd Financial Partners LLC2,741$825K0.1%N/A0.002%
8/10/2026 West Family Investments Inc.767$231K0.1%N/A0.001%
8/10/2026 NewEdge Wealth LLC9,094$2.74M0.0%N/A0.007%
8/10/2026 Danske Bank A S64,555$19.43M0.0%N/A0.048%
8/8/2026 Wealthfront Advisers LLC9,554$2.88M0.0%N/A0.007%
8/8/2026 Meeder Advisory Services Inc.1,611$485K0.0%N/A0.001%
8/8/2026 Meeder Asset Management Inc.1,570$473K0.0%N/A0.001%
8/7/2026 Citizens Financial Group Inc. RI3,682$1.11M0.0%N/A0.003%
8/7/2026 Grandfield & Dodd LLC3,204$964K0.1%N/A0.002%
8/7/2026 Pallas Capital Advisors LLC2,203$663K0.0%N/A0.002%
8/7/2026 Mitsubishi UFJ Asset Management Co. Ltd.168,664$50.77M0.0%N/A0.126%
8/7/2026 Plato Investment Management Ltd3,671$1.10M0.1%N/A0.003%
8/6/2026 J.Safra Asset Management Corp3,122$940K0.0%N/A0.002%
8/6/2026 Flputnam Investment Management Co.2,761$831K0.0%N/A0.002%
8/6/2026 Global Retirement Partners LLC1,893$570K0.0%N/A0.001%
8/6/2026 SCS Capital Management LLC115,549$34.78M0.3%N/A0.086%
8/6/2026 Bank of New York Mellon Corp492,071$148.13M0.0%N/A0.368%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
8/6/2026 Focus Partners Advisor Solutions LLC1,133$341K0.0%N/A0.001%
8/6/2026 S&CO Inc.7,400$2.23M0.1%N/A0.006%
8/6/2026 Clearstead Trust LLC3,940$1.19M0.2%N/A0.003%
7/10/2026 Tema ETFs LLC1,930$581K0.0%-2.1%0.001%
7/10/2026 Generali Investments Management Co LLC946$285K0.1%-22.9%0.001%
7/10/2026 Handelsbanken Fonder AB107,255$32.29M0.1%-21.4%0.080%
7/10/2026 Perkins Coie Trust Co97$29K0.0%-58.5%0.000%
7/10/2026 Fulton Bank N.A.1,505$453K0.0%-2.8%0.001%
7/10/2026 Wealthcare Advisory Partners LLC1,280$385K0.0%-3.8%0.001%
7/9/2026 Everhart Financial Group Inc.2,646$797K0.1%-8.8%0.002%


ALNY Institutional Ownership - Frequently Asked Questions

During the previous two years, 832 institutional investors and hedge funds held shares of Alnylam Pharmaceuticals. The most heavily invested institutionals were Capital World Investors ($6.48B), Vanguard Group Inc. ($5.39B), Capital Research Global Investors ($2.70B), Geode Capital Management LLC ($1.06B), Baillie Gifford & Co. ($1.03B), Norges Bank ($895.82M), and Dodge & Cox ($781.15M).Learn more on Alnylam Pharmaceuticals' institutional investors.

92.97% of Alnylam Pharmaceuticals' stock is owned by institutional investors. Learn more on ALNY's institutional investor holdings.

Of the 752 institutional investors that purchased Alnylam Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Norges Bank ($6.74M), Regeneron Pharmaceuticals Inc. ($4.44M), Groupama Asset Managment ($2.51M), Capital Research Global Investors ($1.76M), Arrowstreet Capital Limited Partnership ($1.35M), T. Rowe Price Investment Management Inc. ($1.28M), and AQR Capital Management LLC ($1.05M).

Institutional investors have bought a total of 18,857,036 shares in the last 24 months. This purchase volume represents approximately $7.62B in transactions.

Of the 306 institutional investors that sold Alnylam Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deerfield Management Company L.P. ($110.08M), Invesco Ltd. ($45.50M), Ameriprise Financial Inc. ($4.47M), Groupama Asset Managment ($4.00M), Amundi ($3.21M), Regeneron Pharmaceuticals Inc. ($3.05M), and Man Group plc ($2.85M).

Institutional investors have sold a total of 197,343,176 shares in the last 24 months. This volume of shares sold represents approximately $88.86B in transactions.



Institutional ownership data for NASDAQ:ALNY is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/23/2026. New 13F filings are added each quarter as they're published.
From Our Partners